Andreas Clemens

Andreas Clemens (born 6 May 1966) is a German physician and pharmaceutical executive. He is a specialist in internal medicine, endocrinology, and diabetology and has held senior leadership positions in medical development and medical affairs within the global pharmaceutical industry. He currently serves as Executive Director and Global Head of Medical Affairs, Immunology at Novartis.

Early life and education Clemens was born in Hildesheim, Lower Saxony. He studied medicine at the Georg-August University of Göttingen and received his MD in 1994. He subsequently completed postgraduate training in internal medicine, endocrinology, and diabetology at university hospitals in Kiel and Heidelberg. In 2016 he earned the German post-doctoral qualification Dr. med. habil. in internal medicine with a focus on cardiology at the Johannes Gutenberg University Mainz, which entitled him to teach as a Privatdozent.

His research has focused on pharmaceutical drug development in thrombosis, cardiology, endocrinology, ophthalmology, and rare diseases, including early contributions to the clinical development of dabigatran etexilate.

He serves as an associate editor of the journal Contemporary Clinical Trials.

Other activities Clemens is a member of the foundation board of the European Association for Vision and Eye Research (EVERf).

He is also active in academic teaching and has lectured at the University of Freiburg and the Johannes Gutenberg University Mainz.